Form D · Biotechnology
Cellceutix CORP
Beverly, MA · CIK 0001355250
Offering snapshot reported May 10, 2012 · SEC filing
- Reported sold
- $100K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 8, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2012 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jan 25, 2012 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 25, 2012 | Amendment | $1,000,000 | $0vs Jan 25, 2012 | 1 | SEC filing |
| Jul 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06, 46
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-177972
Source: Form D, filed May 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Krishna Dr, Menon | Director, Executive |
| Krishna Dr. Menon | Director, Executive |
| Leo Ehrlich | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Cumming Center Suite 151 B
Beverly, MA, 01915
Beverly, MA, 01915